Merck Letter on the Global Supply of SINEMET

Many in the Parkinson's community have heard about a possible shortage of the prescription drug SINEMET in some countries in Europe.  Although there is no problem with the supply of SINEMET in the United States, many of you may be interested in a letter PAN received from Dr. Michael Rosenblatt, Merck’s Chief Medical Officer, with information about the global supply situation.  Please feel free to share the letter with others as you see fit.

Download the letter as a PDF.